Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Bags Barron As R&D Boss As Vallance Joins UK Government

Executive Summary

UK pharma giant GlaxoSmithKline has nabbed a high-profile figure from Google's Calico to head up its research efforts. Barron's oncology pedigree from his time at Roche suggests that cancer is again a core area for GSK.

Advertisement

Related Content

New CFO Mackay Completes Top Table At GSK
GSK's Big Reveal: An R&D Overhaul Poised To Yield Long-Term Cultural Change
For GSK R&D Head Hal Barron 'There's No Place Like Home' For Seeding Innovation
Five Reasons Why GSK Spinning Off Consumer Is Not So Straightforward
Five Reasons Why GSK Spinning Off Consumer Health Wouldn't Be Easy
Pharma Q2 Results Preview: Lilly, Biogen, GSK And Gilead
GSK Gains Clarity For Pharma Focus Through Novartis Consumer JV Buy
GSK Most Likely To Buy Pfizer's Consumer Business – Is It A Step In Wrong Direction?
UK To Offer Firms More Flexible Commercial Deals On ‘Transformative’ Drugs, Earlier Access To Market
GSK Spotlights Three Impending Drug Launches In 3Q Update

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC099844

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel